insights_auto
Why is SGMOQ down 2.91%?
Dive Deeperchevron_right
SGMOQ:OTCMKTS
Sangamo Therapeutics Inc
$0.14
arrow_downward
-2.91%(-0.0042) 1D
Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SGMOQ...
Open
$0.14
High
$0.15
Low
$0.14
Mkt. cap
61.11M
Avg. vol.
1.87M
Volume
897.31K
52-wk high
$0.20
52-wk low
$0.03
EPS
-$0.38
Beta
1.56
Shares outstanding
414.29M
No. of employees
142
Open
$0.14
High
$0.15
Low
$0.14
Mkt. cap
61.11M
Avg. vol.
1.87M
Volume
897.31K
52-wk high
$0.20
52-wk low
$0.03
EPS
-$0.38
Beta
1.56
Shares outstanding
414.29M
No. of employees
142
News stories
From web sources and news partners
DailyForex
·
9 minutes ago
Forex Today 07/10: S&P 500 and Nasdaq Close at Record Highs
Benzinga
·
36 minutes ago
Which 10 Stocks Command 41 Cents of Every S&P 500 Dollar? - State Street SPDR S&P 500 ETF Trust (ARCA:SPY
MarketBeat
·
35 minutes ago
Echostar CORP (NASDAQ:ECHO) Receives Average Recommendation of "Moderate Buy" from Brokerages
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorBiotechnology
Websitesangamo.com